Burr Warns User Fee Renewal Could Be Difficult Without Performance Measure Improvements
Senator tells FDA Commissioner Hamburg that time to market is important metric during hearing dominated by questions about medical device review.
Senator tells FDA Commissioner Hamburg that time to market is important metric during hearing dominated by questions about medical device review.